Below is a list of the videos in the above carousel. This allows you to go straight the videos that are of most interest
Advancing the Therapeutic Role of Nutrition
Capture insights into how the therapeutic role of nutrition is advancing today, for tomorrow and together through the collaboration between healthcare professionals, patients, breakthrough biotech leaders and Nestlé Health Science.
The quest for innovation is strong across fields as diverse as gastrointestinal sensitivities, oncology, infant food allergy to new technology platforms such as the microbiome and amino acids; it is an innovation frontier expanding the boundaries of nutrition, health and wellness.
Sharing Solutions for Gastrointestinal Sensitivities
Gastrointestinal sensitivities – including Irritable Bowel Syndrome (IBS) – are a major personal and health economic burden. Managing IBS can cost up to 20bn dollars in the USA alone.1
Learn how Nestlé Health Science is helping advance the adoption of a pioneering dietary approach – developed by experts at Monash University, Australia – that limits dietary sugars associated with IBS symptoms.
1 Reference: https://www.ncbi.nlm.nih.gov/pubmed/15298528
Inspired by a Shared Goal: Seizure Control
Pediatric epilepsy impacts not just the child, but also the wider family. A significant proportion of patients don't respond to mainline drugs but experts are advancing understanding and adoption of ketogenic dietary therapy. It switches patient’s metabolism to burning fat rather than carbohydrates as a source of energy.
Innovative products such as those developed by Vitaflo, have a key role as part of a wider educational effort to enable parents and carers to make a palatable diet that patients can adhere to. Seizure control is transforming lives.
Mastering the Microbiome
The ability to analyze microorganisms is today unraveling the mysterious of the microbiome – the 100 trillion microorganisms that live within us. An unhealthy or so-called dysbiotic microbiome is now understood to be an underlying cause of a range of health conditions.
Nestlé Health Science partner, Seres Therapeutics, is a leader in the field, exploring its microbial strains to develop therapeutics that aim to make the microbiome well again. An ability to diagnose, feed and treat the microbiome – creating a transformational health technology platform is within reach.
Fast Forwarding Therapies: From the Food Proteome
Amino acids have long been recognized as the building blocks of protein, but today breakthroughs are being made revealing that amino acid imbalance may have be causal factor in a multitude of disease states.
Nestlé Health Science partner Axcella Health is exploring the human diet to identify proteins that have the amino acid signature capable of restoring cellular balance and thereby treating the underlying cause of the disease. It’s a new therapeutic modality in the making.
Shortening the Journey: in diagnosing Cow’s Milk Protein Allergy
Cow’s Milk Protein Allergy is the most common infant food allergy in the first year of life; yet it’s range of non-specific symptoms make it difficult to recognize, leading to delays in therapeutic intervention.
Experts, supported by Nestlé Health Science, are however introducing a simple to use scoring tool – the Cow’s Milk Related Symptom Score – enabling primary healthcare professionals to interpret symptoms and consider earlier intervention. An innovative skin patch diagnostic tool is also in development in this dynamic field of therapeutic advance.